[A Biopharmaceutical Company with Two First-in-Class Drug Candidates | Pharmazz, Inc. Pharmazz, Inc. has two first-in-class drug candidates with positive Phase 3 data in acute cerebral ischemic stroke and hypovolemic shock and a seasoned management team. ]